Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1979 1
1980 2
1985 1
1988 2
1989 1
1990 2
1991 1
1992 2
1994 1
1995 2
1997 3
1998 1
1999 1
2000 1
2001 1
2002 6
2003 2
2004 5
2005 9
2006 13
2007 11
2008 10
2009 5
2010 5
2012 7
2013 4
2014 5
2015 3
2016 2
2017 2
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15563560

108 results
Results by year
Filters applied: . Clear all
Page 1
Mouse models of diabetic nephropathy.
Breyer MD, Böttinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K; AMDCC. Breyer MD, et al. J Am Soc Nephrol. 2005 Jan;16(1):27-45. doi: 10.1681/ASN.2004080648. Epub 2004 Nov 24. J Am Soc Nephrol. 2005. PMID: 15563560 Free article. Review.
Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
Nakhoul F, Nakhoul N, Asleh R, Miller-Lotan R, Levy AP. Nakhoul F, et al. Diabetes Res Clin Pract. 2013 Jun;100(3):289-97. doi: 10.1016/j.diabres.2013.02.004. Epub 2013 Mar 13. Diabetes Res Clin Pract. 2013. PMID: 23490597 Review.
Diabetic nephropathy: of mice and men.
Breyer MD, Böttinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K. Breyer MD, et al. Adv Chronic Kidney Dis. 2005 Apr;12(2):128-45. doi: 10.1053/j.ackd.2005.01.004. Adv Chronic Kidney Dis. 2005. PMID: 15822049 Review.
A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE, Rinchik EM, Polosukhina D, Davis LS, Kadkina V, Mohamed Y, Dunn SR, Sharma K, Qi Z, Fogo AB, Breyer MD. Tchekneva EE, et al. J Am Soc Nephrol. 2007 Jan;18(1):103-12. doi: 10.1681/ASN.2006020164. Epub 2006 Dec 6. J Am Soc Nephrol. 2007. PMID: 17151334 Free article.
Diabetic nephropathy--are there differences between type I and type II?
Ritz E, Hasslacher C, Tschöpe W. Ritz E, et al. Miner Electrolyte Metab. 1990;16(1):69-72. Miner Electrolyte Metab. 1990. PMID: 2182996 Review.
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM, Mauer M; International Diabetic Nephropathy Study Group. Steinke JM, et al. Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Pediatr Endocrinol Rev. 2008. PMID: 18806710 Review.
Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook.
Dwyer JP, Lewis JB. Dwyer JP, et al. Med Clin North Am. 2013 Jan;97(1):53-8. doi: 10.1016/j.mcna.2012.10.006. Epub 2012 Nov 27. Med Clin North Am. 2013. PMID: 23290729 Review.
Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.
Yang J, Zhang D, Li J, Zhang X, Fan F, Guan Y. Yang J, et al. Clin Sci (Lond). 2009 Jan;116(1):17-26. doi: 10.1042/CS20070462. Clin Sci (Lond). 2009. PMID: 19037881 Review.
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
Soler MJ, Riera M, Batlle D. Soler MJ, et al. Exp Diabetes Res. 2012;2012:616313. doi: 10.1155/2012/616313. Epub 2012 Feb 8. Exp Diabetes Res. 2012. PMID: 22461787 Free PMC article. Review.
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.
Severson DL. Severson DL. Can J Physiol Pharmacol. 2004 Oct;82(10):813-23. doi: 10.1139/y04-065. Can J Physiol Pharmacol. 2004. PMID: 15573141 Review.
108 results
Jump to page
Feedback